台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP06-01: Impact of obesity on the outcome of prostate cancer post robot-assisted radical prostatectomy

2021-05-24 • 觀看: 1208 • 回應: 0 • doc
MP05-10: Results of bevacizumab plus erlotinib in patients with metastatic type 2 papillary renal cell cancer - experience in Taipei Veterans General Hospital

2021-05-24 • 觀看: 1811 • 回應: 0 • doc
MP05-09: Glutathione s-transferase Mu 5 plays anti-tumor activity in bladder cancer cells

2021-05-24 • 觀看: 1177 • 回應: 0 • doc
MP05-08: Anti-cancer effects and tumor marker role of glutathione s-transferase mu 5 in human bladder cancer

2021-05-24 • 觀看: 1185 • 回應: 0 • doc
MP05-07: Hyperthermia inhibits chemotherapeutic drug resistance of bladder cancer cells through epithelial mesenchymal transition down-regulation

2021-05-24 • 觀看: 1147 • 回應: 0 • doc
MP05-06: External validation of Likert scale for predicting non-muscle invasive bladder cancer, KCGMH experience

2021-05-24 • 觀看: 1098 • 回應: 0 • doc
MP05-05: Cadherin-11 regulates cell pyroptosis and induces anti-tumor immunity through PD-L1 in bladder cancer

2021-05-24 • 觀看: 1247 • 回應: 0 • doc
MP05-04: The attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer by targeting MMP-2 expression

2021-05-24 • 觀看: 1173 • 回應: 0 • doc
MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma

2021-05-24 • 觀看: 1406 • 回應: 0 • doc
MP05-02: PR-619, an inhibitor of deubiquitylating enzymes, reverses drug resistance in cisplatin-resistant urothelial carcinoma cells via suppression of c-myc

2021-05-24 • 觀看: 1181 • 回應: 0 • doc
MP05-01: The prognostic impact of tumour architecture for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis

2021-05-24 • 觀看: 1197 • 回應: 0 • doc
MP04-10: Strangulated urethral prolapse occurring in a patient being treated for central precocious puberty

2021-05-24 • 觀看: 1432 • 回應: 0 • doc

Prev
476
477
478
479
480
481
482
483
484
485
Next
/ 1052